Clinical trial
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation: A Randomized, Controlled Trial
NCT07092618 is registered in ClinicalTrials.gov with AgelessRx as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation: A Randomized, Controlled Trial
- Lead sponsor
- AgelessRx
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- December 17, 2024
- Completion date
- August 31, 2025
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aging, geroscience, glp-1, longevity